Plasmapheresis, Intravenous Immunoglobin Show Promise as Early Treatment for COVID-19 - Pharmacy Times
Plasmapheresis, Intravenous Immunoglobin Show Promise as Early Treatment for COVID-19 - Pharmacy Times Plasmapheresis, Intravenous Immunoglobin Show Promise as Early Treatment for COVID-19 - Pharmacy Times PlantForm signs agreement with Bio-Manguinhos/Fiocruz to develop a biosimilar pembrolizumab cancer drug - PRNewswire Merck Announces First-Quarter 2021 Financial Results - StreetInsider.com Plasmapheresis, Intravenous Immunoglobin Show Promise as Early Treatment for COVID-19 - Pharmacy Times Posted: 29 Apr 2021 07:17 AM PDT Plasmapheresis and intravenous immunoglobulin (IVIG) have been reported to be effective empirical therapeutic options to control COVID-19 infection. A metanalysis published in SN Comprehensive Clinical Medicine found that administering the therapies early in a patient's treatment could be associated with better outcomes. Plasmapheresis, the process of separating the plasma from blood cells, ...